Pellino 2 Inhibitors
Pellino 2 inhibitors represent a diverse array of chemicals that modulate Pellino 2 activity through indirect mechanisms. These compounds target specific pathways, leading to the inhibition of Pellino 2 within intricate signaling networks. BX-795, an inhibitor of PDK1, indirectly inhibits Pellino 2 by disrupting the PI3K-Akt signaling pathway. It affects the activation of Akt, leading to downstream events that modulate Pellino 2 expression and function. TAK-632, a MEK inhibitor, indirectly inhibits Pellino 2 by targeting the MAPK/ERK signaling pathway, influencing the activity of MEK and impacting Pellino 2 within cellular processes associated with this pathway. LY294002, a PI3K inhibitor, interferes with the activation of PI3K, leading to downstream events that modulate Pellino 2 expression and function. U0126, a MEK1/2 inhibitor, influences the activity of MEK1/2, impacting Pellino 2 within cellular processes associated with the MAPK/ERK pathway. GDC-0941, a pan-PI3K inhibitor, disrupts the PI3K-Akt signaling pathway, modulating Pellino 2 expression and function.
PD98059, a MEK inhibitor, influences the activity of MEK, leading to downstream events that impact Pellino 2 within cellular processes associated with the MAPK/ERK pathway. Wortmannin, a PI3K inhibitor, interferes with the activation of PI3K, modulating Pellino 2 expression and function. Cobimetinib, a MEK inhibitor, influences the activity of MEK, impacting Pellino 2 within cellular processes associated with the MAPK/ERK pathway. IC87114, a PI3Kδ inhibitor, disrupts the PI3K-Akt signaling pathway, modulating Pellino 2 expression and function. Trametinib, a MEK inhibitor, influences the activity of MEK, leading to downstream events that impact Pellino 2 within cellular processes associated with the MAPK/ERK pathway. Triciribine, an Akt inhibitor, interferes with the activation of Akt, leading to downstream events that modulate Pellino 2 expression and function within cellular processes associated with the PI3K-Akt pathway. These inhibitors collectively provide valuable tools for understanding the intricate regulatory networks involving Pellino 2 in cellular signaling.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BX 795 | 702675-74-9 | sc-281689 sc-281689A sc-281689C sc-281689B sc-281689D sc-281689E | 2 mg 5 mg 10 mg 25 mg 50 mg 100 mg | $219.00 $273.00 $331.00 $495.00 $882.00 $1489.00 | 5 | |
BX-795, an inhibitor of PDK1, indirectly inhibits Pellino 2 by disrupting the PI3K-Akt signaling pathway. It affects the activation of Akt, which subsequently influences downstream events leading to the modulation of Pellino 2 expression and function within cellular processes associated with the PI3K-Akt pathway. | ||||||
TAK 632 | 1228591-30-7 | sc-473801 | 5 mg | $224.00 | ||
TAK-632, a MEK inhibitor, indirectly inhibits Pellino 2 by targeting the MAPK/ERK signaling pathway. By modulating the activity of MEK, TAK-632 influences downstream signaling events that impact Pellino 2 expression and function within cellular processes associated with the MAPK/ERK pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002, a PI3K inhibitor, indirectly inhibits Pellino 2 by disrupting the PI3K-Akt signaling pathway. It interferes with the activation of PI3K, leading to downstream events that modulate Pellino 2 expression and function within cellular processes associated with the PI3K-Akt pathway. | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $184.00 $195.00 | 2 | |
GDC-0941, a pan-PI3K inhibitor, indirectly inhibits Pellino 2 by disrupting the PI3K-Akt signaling pathway. It affects the activation of PI3K, leading to downstream events that modulate Pellino 2 expression and function within cellular processes associated with the PI3K-Akt pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059, a MEK inhibitor, indirectly inhibits Pellino 2 by targeting the MAPK/ERK signaling pathway. By modulating the activity of MEK, PD98059 influences downstream signaling events that impact Pellino 2 expression and function within cellular processes associated with the MAPK/ERK pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin, a PI3K inhibitor, indirectly inhibits Pellino 2 by disrupting the PI3K-Akt signaling pathway. It interferes with the activation of PI3K, leading to downstream events that modulate Pellino 2 expression and function within cellular processes associated with the PI3K-Akt pathway. | ||||||
Cobimetinib | 934660-93-2 | sc-507421 | 5 mg | $270.00 | ||
Cobimetinib, a MEK inhibitor, indirectly inhibits Pellino 2 by targeting the MAPK/ERK signaling pathway. It influences the activity of MEK, leading to downstream events that impact Pellino 2 expression and function within cellular processes associated with the MAPK/ERK pathway. | ||||||
IC-87114 | 371242-69-2 | sc-364509 sc-364509A | 5 mg 50 mg | $140.00 $1060.00 | 1 | |
IC87114, a PI3Kδ inhibitor, indirectly inhibits Pellino 2 by disrupting the PI3K-Akt signaling pathway. It interferes with the activation of PI3Kδ, leading to downstream events that modulate Pellino 2 expression and function within cellular processes associated with the PI3K-Akt pathway. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $112.00 $163.00 $928.00 | 19 | |
Trametinib, a MEK inhibitor, indirectly inhibits Pellino 2 by targeting the MAPK/ERK signaling pathway. It influences the activity of MEK, leading to downstream events that impact Pellino 2 expression and function within cellular processes associated with the MAPK/ERK pathway. | ||||||
CAL-101 | 870281-82-6 | sc-364453 | 10 mg | $189.00 | 4 | |
CAL-101, a PI3Kδ inhibitor, indirectly inhibits Pellino 2 by disrupting the PI3K-Akt signaling pathway. It interferes with the activation of PI3Kδ, leading to downstream events that modulate Pellino 2 expression and function within cellular processes associated with the PI3K-Akt pathway. | ||||||